351 related articles for article (PubMed ID: 26027638)
1. Drug discovery in prostate cancer mouse models.
Valkenburg KC; Pienta KJ
Expert Opin Drug Discov; 2015; 10(9):1011-24. PubMed ID: 26027638
[TBL] [Abstract][Full Text] [Related]
2. Patient-Derived Xenograft Models for Translational Prostate Cancer Research and Drug Development.
Philp LK
Methods Mol Biol; 2024; 2806():153-185. PubMed ID: 38676802
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer models for novel drug discovery.
Golovko D; Kedrin D; Yilmaz ÖH; Roper J
Expert Opin Drug Discov; 2015; 10(11):1217-29. PubMed ID: 26295972
[TBL] [Abstract][Full Text] [Related]
4. Animal models for modeling pancreatic cancer and novel drug discovery.
Bisht S; Feldmann G
Expert Opin Drug Discov; 2019 Feb; 14(2):127-142. PubMed ID: 30657339
[TBL] [Abstract][Full Text] [Related]
5. Pre-clinical mouse models of human prostate cancer and their utility in drug discovery.
Park SI; Kim SJ; McCauley LK; Gallick GE
Curr Protoc Pharmacol; 2010 Dec; Chapter 14():Unit 14.15. PubMed ID: 21483646
[TBL] [Abstract][Full Text] [Related]
6. Xenograft and genetically engineered mouse model systems of osteosarcoma and Ewing's sarcoma: tumor models for cancer drug discovery.
Sampson VB; Kamara DF; Kolb EA
Expert Opin Drug Discov; 2013 Oct; 8(10):1181-9. PubMed ID: 23844615
[TBL] [Abstract][Full Text] [Related]
7. Mouse models in squamous cell lung cancer: impact for drug discovery.
Singh AP; Adrianzen Herrera D; Zhang Y; Perez-Soler R; Cheng H
Expert Opin Drug Discov; 2018 Apr; 13(4):347-358. PubMed ID: 29394493
[TBL] [Abstract][Full Text] [Related]
8. The use of zebrafish model in prostate cancer therapeutic development and discovery.
Amawi H; Aljabali AAA; Boddu SHS; Amawi S; Obeid MA; Ashby CR; Tiwari AK
Cancer Chemother Pharmacol; 2021 Mar; 87(3):311-325. PubMed ID: 33392639
[TBL] [Abstract][Full Text] [Related]
9. Drug discovery in advanced prostate cancer: translating biology into therapy.
Yap TA; Smith AD; Ferraldeschi R; Al-Lazikani B; Workman P; de Bono JS
Nat Rev Drug Discov; 2016 Oct; 15(10):699-718. PubMed ID: 27444228
[TBL] [Abstract][Full Text] [Related]
10. Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery.
Ruggeri BA; Camp F; Miknyoczki S
Biochem Pharmacol; 2014 Jan; 87(1):150-61. PubMed ID: 23817077
[TBL] [Abstract][Full Text] [Related]
11. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
Amoedo ND; Obre E; Rossignol R
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
[TBL] [Abstract][Full Text] [Related]
12. Zebrafish xenograft models of cancer and metastasis for drug discovery.
Brown HK; Schiavone K; Tazzyman S; Heymann D; Chico TJ
Expert Opin Drug Discov; 2017 Apr; 12(4):379-389. PubMed ID: 28277839
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo culture of human prostate tissue and drug development.
Centenera MM; Raj GV; Knudsen KE; Tilley WD; Butler LM
Nat Rev Urol; 2013 Aug; 10(8):483-7. PubMed ID: 23752995
[TBL] [Abstract][Full Text] [Related]
14. Drug design strategies for the treatment of prostate cancer.
Lauer RC; Friend SC; Rietz C; Pasqualini R; Arap W
Expert Opin Drug Discov; 2015 Jan; 10(1):81-90. PubMed ID: 25366417
[TBL] [Abstract][Full Text] [Related]
15. In Vivo Pharmacology Models for Cancer Target Research.
Chen D; An X; Ouyang X; Cai J; Zhou D; Li QX
Methods Mol Biol; 2019; 1953():183-211. PubMed ID: 30912023
[TBL] [Abstract][Full Text] [Related]
16. Three-Dimensional Cell Cultures as an In Vitro Tool for Prostate Cancer Modeling and Drug Discovery.
Fontana F; Raimondi M; Marzagalli M; Sommariva M; Gagliano N; Limonta P
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32948069
[TBL] [Abstract][Full Text] [Related]
17. New drugs for prostate cancer.
Alifrangis C; O'Hanlon-Brown C; Tuthill M; Waxman J
BJU Int; 2012 Jun; 109(12):1801-6. PubMed ID: 21933331
[TBL] [Abstract][Full Text] [Related]
18. PSMA expression in the Hi-Myc model; extended utility of a representative model of prostate adenocarcinoma for biological insight and as a drug discovery tool.
Simons BW; Turtle NF; Ulmert DH; Abou DS; Thorek DLJ
Prostate; 2019 May; 79(6):678-685. PubMed ID: 30656716
[TBL] [Abstract][Full Text] [Related]
19. Mouse tumour models to guide drug development and identify resistance mechanisms.
Das Thakur M; Pryer NK; Singh M
J Pathol; 2014 Jan; 232(2):103-11. PubMed ID: 24122209
[TBL] [Abstract][Full Text] [Related]
20. The latest animal models of ovarian cancer for novel drug discovery.
Magnotti E; Marasco WA
Expert Opin Drug Discov; 2018 Mar; 13(3):249-257. PubMed ID: 29338446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
